Antonio Carrieri

2.2k total citations
99 papers, 1.8k citations indexed

About

Antonio Carrieri is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Antonio Carrieri has authored 99 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 29 papers in Organic Chemistry and 24 papers in Pharmacology. Recurrent topics in Antonio Carrieri's work include Computational Drug Discovery Methods (22 papers), Receptor Mechanisms and Signaling (20 papers) and Cholinesterase and Neurodegenerative Diseases (15 papers). Antonio Carrieri is often cited by papers focused on Computational Drug Discovery Methods (22 papers), Receptor Mechanisms and Signaling (20 papers) and Cholinesterase and Neurodegenerative Diseases (15 papers). Antonio Carrieri collaborates with scholars based in Italy, Spain and France. Antonio Carrieri's co-authors include Angelo Carotti, Filomena Corbo, Alessia Carocci, Cosimo Altomare, Antonio Rosato, Carlo Franchini, Maria Pigini, Alessia Catalano, Wilma Quaglia and Alessandro Piergentili and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

Antonio Carrieri

93 papers receiving 1.8k citations

Peers

Antonio Carrieri
Sarel F. Malan South Africa
Antonio Carrieri
Citations per year, relative to Antonio Carrieri Antonio Carrieri (= 1×) peers Sarel F. Malan

Countries citing papers authored by Antonio Carrieri

Since Specialization
Citations

This map shows the geographic impact of Antonio Carrieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Carrieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Carrieri more than expected).

Fields of papers citing papers by Antonio Carrieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Carrieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Carrieri. The network helps show where Antonio Carrieri may publish in the future.

Co-authorship network of co-authors of Antonio Carrieri

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Carrieri. A scholar is included among the top collaborators of Antonio Carrieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Carrieri. Antonio Carrieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barbarossa, Alexia, Antonio Rosato, Roberta Tardugno, et al.. (2025). Antibiofilm Effects of Plant Extracts Against Staphylococcus aureus. Microorganisms. 13(2). 454–454. 4 indexed citations
2.
Carrieri, Antonio, Sı́lvia Chaves, Leonardo Brunetti, et al.. (2024). Rivastigmine structure-based hybrids as potential multi-target anti-Alzheimer’s drug candidates. Bioorganic Chemistry. 153. 107895–107895.
3.
Purgatorio, Rosa, Т. Н. Борисова, А. В. Варламов, et al.. (2024). Nature-Inspired 1-Phenylpyrrolo[2,1-a]isoquinoline Scaffold for Novel Antiproliferative Agents Circumventing P-Glycoprotein-Dependent Multidrug Resistance. Pharmaceuticals. 17(4). 539–539.
4.
Mallamaci, Rosanna, Alexia Barbarossa, Antonio Carrieri, Daniela Meleleo, & Alessia Carocci. (2024). Evaluation of the Potential Cytoprotective Effect of Melatonin in Comparison with Vitamin E and Trolox against Cd2+-Induced Toxicity in SH-SY5Y, HCT 116, and HepG2 Cell Lines. International Journal of Molecular Sciences. 25(15). 8055–8055. 4 indexed citations
5.
Barbarossa, Alexia, Antonio Rosato, Antonio Carrieri, et al.. (2023). Antifungal Biofilm Inhibitory Effects of Combinations of Diclofenac and Essential Oils. Antibiotics. 12(12). 1673–1673. 9 indexed citations
6.
Carocci, Alessia, Alexia Barbarossa, Antonio Carrieri, et al.. (2022). Novel Phenothiazine/Donepezil-like Hybrids Endowed with Antioxidant Activity for a Multi-Target Approach to the Therapy of Alzheimer’s Disease. Antioxidants. 11(9). 1631–1631. 18 indexed citations
8.
Carrieri, Antonio, Rosa Purgatorio, Marco Catto, et al.. (2021). Enantiomeric Separation and Molecular Modelling of Bioactive 4-Aryl-3,4-dihydropyrimidin-2(1H)-one Ester Derivatives on Teicoplanin-Based Chiral Stationary Phase. Separations. 9(1). 7–7. 5 indexed citations
9.
Purgatorio, Rosa, Л. Н. Куликова, Leonardo Pisani, et al.. (2020). Scouting around 1,2,3,4‐Tetrahydrochromeno[3,2‐c]pyridin‐10‐ones for Single‐ and Multitarget Ligands Directed towards Relevant Alzheimer's Targets. ChemMedChem. 15(20). 1947–1955. 12 indexed citations
10.
Purgatorio, Rosa, Modesto de Candia, Marco Catto, et al.. (2019). Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease. European Journal of Medicinal Chemistry. 177. 414–424. 53 indexed citations
11.
Catto, Marco, et al.. (2019). Chasing ChEs-MAO B Multi-Targeting 4-Aminomethyl-7-Benzyloxy-2H-Chromen-2-ones. Molecules. 24(24). 4507–4507. 18 indexed citations
12.
Niso, Mauro, Leonardo Pisani, Antonio Carrieri, et al.. (2018). 1,2,3,4-Tetrahydroisoquinoline/2H-chromen-2-one conjugates as nanomolar P-glycoprotein inhibitors: Molecular determinants for affinity and selectivity over multidrug resistance associated protein 1. European Journal of Medicinal Chemistry. 161. 433–444. 16 indexed citations
13.
Trapani, Adriana, Nicolino De Laurentis, Domenico Armenise, et al.. (2015). Enhanced solubility and antibacterial activity of lipophilic fluoro-substituted N-benzoyl-2-aminobenzothiazoles by complexation with β-cyclodextrins. International Journal of Pharmaceutics. 497(1-2). 18–22. 6 indexed citations
14.
Carrieri, Antonio, Marilena Muraglia, Filomena Corbo, & Concetta Pacifico. (2008). 2D- and 3D-QSAR of Tocainide and Mexiletine analogues acting as Nav1.4 channel blockers. European Journal of Medicinal Chemistry. 44(4). 1477–1485. 19 indexed citations
15.
Candia, Modesto de, Luciana Summo, Antonio Carrieri, et al.. (2003). Investigation of platelet aggregation inhibitory activity by phenyl amides and esters of piperidinecarboxylic acids. Bioorganic & Medicinal Chemistry. 11(7). 1439–1450. 15 indexed citations
16.
Carotti, Angelo, Antonio Carrieri, Stefano Chimichi, et al.. (2002). Natural and synthetic geiparvarins are strong and selective MAO-B inhibitors. synthesis and SAR studies. Bioorganic & Medicinal Chemistry Letters. 12(24). 3551–3555. 87 indexed citations
17.
Carotti, Angelo, Antonio Carrieri, Saverio Cellamare, et al.. (2001). Extended form of a retro-inverso peptide stabilized by ?-sheet unidirectional H-bonds: Crystallographic and NMR evidence. Biopolymers. 60(4). 322–332. 8 indexed citations
18.
Chiasserini, Luisa, Cesare Pellerano, Giovanni Biggio, et al.. (2001). High affinity central benzodiazepine receptor ligands. Part 2: quantitative structure–activity relationships and comparative molecular field analysis of pyrazolo[4,3-c]quinolin-3-ones. Bioorganic & Medicinal Chemistry. 9(2). 431–444. 20 indexed citations
19.
Carrieri, Antonio, et al.. (1999). Comparative molecular field analysis of some pyridazinone-containing α1-Antagonists. Bioorganic & Medicinal Chemistry. 7(11). 2615–2620. 9 indexed citations
20.
Carrieri, Antonio, et al.. (1994). Papain catalyzed hydrolysis of aryl esters: a comparison of the Hansch, Docking and CoMFA methods. CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026